 World News
 USA (195)
 Bay Area
 San Francisco (1278)
South SF (88)
 Genentech
2007 (6)
2006 (14)
2005 (6)
2004 (7)
2003 (5)
2002 (2)
2001 (2)
 Genentech on Wikipedia
 Genentech on Web
 Real Estate
 Chart
|
|
|
| Mon. |
|
Roche Offers $44B For Remaining Shares| Roche Holding, which already owns 55.9%, was offering $43.7 billion to take over the remaining shares of Genentech | |
|
|
| Apr.30 |
|
Bad news on cancer drug Rituxan| Shares in Genentech sagged, after the company said Rituxan failed to curb symptoms of the debilitating autoimmune disorder | |
|
| Apr.24 |
|
Court slashes $200 million from judgment| The company has been ordered to pay $500 million to a Southern California hospital for failing to pay royalties | |
|
|
| Feb.22 |
|
FDA Clears Avastin for Breast Cancer| A Genentech drug received federal approval, a surprise decision | | |
|
| |
Bankruptcy for Sharper Image
|
|
| Jan.14 |
|
4Q Profit Rises 6 Percent The biotech giant barely scraped past expectations as stock dropped in after-hours trading as sales of a key product also fell below expectations
|
|
| Dec.5 |
|
FDA Panel Rejects Avastin, stock drops Shares dropped nearly 9% after a panel of medical experts said FDA should deny approval of the company's blockbuster drug
|
| Oct.16 |
|
3Q Profit Up 21 % On Cancer Drug Sales The profit rose nearly 21% from a year ago, beating expectations by a penny thanks to stronger-than-expected sales of the Avastin
|
| Aug.3 |
|
Genentech completes Tanox acquisition
|
| |
Arrest Warrant For Supe Jew For Perjury
|
| Mar.24 |
|
Genentech projects quarter to be 'flat'
|
| Jan.10 |
|
4Q Earnings Soar 75% A strong demand for cancer-fighting drugs fueled a profit increase as company executives shook off doubts
|
|
| Dec.21 |
|
Genentech gets rights to drug
|
| Nov.11 |
|
Genentech to acquire partner Tanox Genentech Inc. has agreed to its first acquisition ever - Tanox Inc., co-developer of the asthma medicine Xolair
|
| |
49ers dump Candlestick for Santa Clara
|
| Sep.12 |
|
Avastin approval slowed by FDA
|
| Aug.12 |
|
Cancer drug review extended FDA has extended by up to 90 days its review of Herceptin for treatment of patients with breast cancer.
|
| Aug.8 |
|
Genentech has plans to expand
|
| Jul.31 |
|
Tony Blair Visits Genentech Headquarters Heavy hitters from biotech firms sat down for an extraordinary talk with British Prime Minister
|
| Jul.11 |
|
2Q Profit Soars to $531 Million The biotechnology company blew past Wall Street expectations with a 79% surge in second quarter earnings
|
| Jul.1 |
|
FDA approves blindness drug Genentech Inc. won approval to market Lucentis, to restore sight in patients afflicted with a common eye disease
|
| Jun.29 |
|
2 drugs set to fight blindness
|
| Apr.12 |
|
Profit climbs by 48% in first quarter Genentech Inc. raised its full-year earnings growth estimate to as much as 55% over 2005
|
| |
SF Picks Google, EarthLink For Wi-Fi
|
| Feb.13 |
|
Cancer Drug Trials Scaled Back Avastin only targets cancer, and leaves healthy cells alone
|
| Jan.11 |
|
Up 64% in quarter after good year Earnings per share grew 63 percent to 31 cents as cancer drugs continued to build sales
|
|
| Jul.11 |
|
Profits Soar 73% in 2Q The second quarter profit is fueled by continued strong drug sales. The results exceeded the estimate by 4 cents
|
| Apr.16 |
|
Avastin helps those with breast cancer Genentech Inc.'s pioneering colon cancer is already showing potential as a lung cancer treatment
|
| Apr.12 |
|
Biotech giant's profit up 61% The colon cancer drug Avastin and other cancer drugs boost sales
|
| |
Bonds gets standing ovation at opener
|
| Jan.10 |
|
4th best place to work for in U.S. Biotechnology rated fourth by Fortune
|
| |
|
Profit surges, misses expectations by 1c Biotechnology titan reported a 63% surge in its fourth-quarter profits on strong sales of a string of new drugs
|
|
| Nov.29 |
|
Avastin helps sickest patients Genentech's novel colon cancer-fighting drug helped some of the patients stay alive 2 months longer than expected
|
| Oct.6 |
|
Profits surge on drug sales
|
| Apr.7 |
|
Profits surge on brisk cancer drug sales
|
| |
Former SFPD chief Fagan Sr. retires
|
| Feb.26 |
|
FDA approves cancer fighter Avastin
|
| |
Officials perform first gay marriages
|
| Jan.14 |
|
Profits surge on strong drug sales
|
|
| Oct.8 |
|
Biotech titan posts higher profits
|
| Aug.15 |
|
Firm: Genentech refuses to share profits. Fremont
|
| May.19 |
|
Encouraging results with cancer drug| Avastin extended the lives of some of the colon cancer patients. Company's stock soaring nearly 45% | |
|
| May.12 |
|
Arthritis drug fails key experiment
|
| May.9 |
|
Janitors will get health insurance
|
|
| Sep.10 |
|
Stock plummets 9.7%
|
| Sep.7 |
|
Big patent win vs. Chiron
|
|
| Oct.11 |
|
$400 million suit against Genentech
|
| |
Bonds hits No. 73
| Genentech | Major Events in 21st Century | 
|
|
Neighbor News Timelines:
Neighbor  Real Estate:
Add a favorite (file a bookmark) to Genentech News Timeline
Please send feedback to: support@mapreport.com
Advertise on Genentech Page
|
Real Estate:
94506 homes,
94501,
94502,
94526 houses,
94509,
94531,
94582 homes,
94540,
94541,
94583 homes,
94542,
94543,
94595 houses,
94544,
94545,
94596 homes,
94546,
94552,
94597 homes,
94550,
94551,
94598 houses,
94557,
94577,
94518 homes,
94578,
94579,
94519 homes,
94608,
94662,
94520 houses,
94701,
94702,
94521 homes,
94703,
94704,
94522 homes,
94705,
94526,
94523 houses,
94706,
94707,
94524 homes,
94708,
94709,
94527 homes,
94710,
94712,
94582 houses,
94720,
94583 homes,
94566 houses,
94568 homes,
94588 houses
|
|
Homes for Sale in East Bay (San Francisco Bay Area)
|
|
